Biotechnology News

Berwyn, Pennsylvania--(Newsfile Corp. - May 10, 2021) -  Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, is pleased to announce that its CEO Maria Maccecchini, Ph.D. will ring The Closing Bell at the New York Stock...
Biotechnology, Pharmaceuticals
2021-05-10 2:00 PM EDT | Annovis Bio, Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 10, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTC Pink: NMDBF) (FSE: 6UF) ("NeonMind" or the "Company"), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, today announced that Robert Tessarolo,...
Biotechnology, Food/Beverages, Health, Psychedelics
2021-05-10 6:00 AM EDT | NeonMind Biosciences Inc

San Diego, California--(Newsfile Corp. - May 10, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today a master service agreement with Clinlogix, a Contract Research Organization (CRO), to support Tryp's clinical devel
Biotechnology, Pharmaceuticals
2021-05-10 4:00 AM EDT | Tryp Therapeutics Inc.

Toronto, Ontario--(Newsfile Corp. - May 10, 2021) - ScreenPro Security Inc. (CSE: SCRN) ("ScreenPro" or the "Company") is pleased to announce that it has started providing COVID-19 testing and screening with supporting travel documents for air passengers travelling on Korean Air Lines Co., Ltd., a founding member of SkyTeam, a...
Technology, Biotechnology
2021-05-10 3:00 AM EDT | ScreenPro Security Ltd.

Vancouver, British Columbia--(Newsfile Corp. - May 7, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative treatments for nerve damage and neurodegenerative diseases, today announced that the Company has granted 800,000 incentive stock options to an Officer...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2021-05-07 7:26 PM EDT | NervGen Pharma Corp.

Vancouver, British Columbia--(Newsfile Corp. - May 7, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), a Canadian biotech Company focused on the development of novel and highly specific vaccines and antibody-drug conjugates targeting cancer and infectious diseases, is pleased to begin its trading on the CSE as...
Biotechnology, Pharmaceuticals, Health
2021-05-07 8:00 AM EDT | Defence Therapeutics Inc.

Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ‎‎(FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has, subject to TSX Venture Exchange Approval, repriced to $0.55 each, and extended the exercise period for two years, the Warrants expiring May 7,...
Biotechnology, Pharmaceuticals, Health
2021-05-06 8:38 PM EDT | Hemostemix Inc.

Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - Universal PropTech Inc. (TSXV: UPI) (OTCQB: UPIPF) (FSE: 8LH) ("UPI" or the "Company") is pleased to announce that the Company's Chief Growth Officer, Frank Carnevale, will be presenting at the Q2 Investor Summit.The conference will be held on Monday May 17th, 2021,...
Biotechnology, Environmental Services, Energy, Utilities
2021-05-06 8:11 PM EDT | Universal PropTech Inc.

Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it has...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-05-06 9:26 AM EDT | Pharmadrug Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) ("Nextleaf", "OILS", or the "Company"), the world's most innovative cannabis extractor, is pleased to announce the following updates around its CBD business:
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2021-05-06 9:00 AM EDT | Nextleaf Solutions Ltd.

Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - ScreenPro Security Inc. (CSE: SCRN) ("ScreenPro" or the "Company") is pleased to announce that the Company launched its medical app device, GoStop, with its film and television clients. ScreenPro has successfully integrated GoStop with its laboratory reporting systems. GoStop is a COVID-19...
Technology, Biotechnology
2021-05-06 8:59 AM EDT | ScreenPro Security Ltd.

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that online sales of its flagship VINIA® product in the United States will commence at 8 A.M. Eastern Time on May 12, 2021, via its vinia.com website.This milestone represents a turning...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Cultivator
2021-05-06 8:55 AM EDT | BioHarvest Sciences Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative treatments for nerve damage and neurodegenerative diseases, is pleased to announce today that the first subject has been dosed with NVG-291...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2021-05-06 8:30 AM EDT | NervGen Pharma Corp.

Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has entered into a distribution agreement to white label and...
Technology, Biotechnology, Health
2021-05-06 7:00 AM EDT | Therma Bright Inc.

Berwyn, Pennsylvania--(Newsfile Corp. - May 6, 2021) -  Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced the U.S. Patent and Trademark Office (USPTO) granted the Company's patent (US 16/504,813) for a method of treating...
Biotechnology, Pharmaceuticals
2021-05-06 6:45 AM EDT | Annovis Bio, Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 5, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, announced that it has priced its previously announced overnight, "best efforts" marketed public...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2021-05-05 11:43 AM EDT | NervGen Pharma Corp.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - May 5, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases,...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2021-05-05 11:42 AM EDT | NervGen Pharma Corp.

Vancouver, British Columbia--(Newsfile Corp. - May 5, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: "1XU1") ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that it has been approved for trading on the OTCQB Venture Market ("OTCQB")...
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2021-05-05 10:30 AM EDT | Entheon Biomedical Corp.

Toronto, Ontario--(Newsfile Corp. - May 5, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that it has been invited to present at the Canaccord Genuity 41st Annual Growth Conference being held August 10-12, 2021.James Lanthier, CEO of Mindset, commented,...
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2021-05-05 7:00 AM EDT | Mindset Pharma Inc.